Conjugation with Tris Decreases the Risk of Ketoprofen-Induced Mucosal Damage and Reduces Inflammation-Associated Methane Production in a Rat Model of Colitis

We have designed a new compound from the non-steroidal anti-inflammatory drug (NSAID) ketoprofen (Ket) and 2-amino-2-(hydroxymethyl)-1,3-propanediol (Tris) precursors, with the aim to reduce the gastrointestinal (GI) side effects of NSAID therapies. We investigated mucosal reactions in a standard ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Ugocsai, Melinda, Bársony, Anett, Varga, Réka Anna, Gajda, Ámos, Vida, Noémi, Lajkó, Norbert, Rónaszéki, Benedek, Tóth, Gábor, Boros, Mihály, Érces, Dániel, Varga, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535093/
https://www.ncbi.nlm.nih.gov/pubmed/37765297
http://dx.doi.org/10.3390/pharmaceutics15092329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535093/
https://www.ncbi.nlm.nih.gov/pubmed/37765297
http://dx.doi.org/10.3390/pharmaceutics15092329

Ejemplares similares